drugset
drugset / Trial / NCT02434549

Botulinum Toxin-A as a Treatment for Chronic Muscle-Related Pain in Adults With Spastic Cerebral Palsy: a Randomized Controlled Trial

NCT02434549 ↗

Phase 2 Terminated 16 enrolled Kristina Tedroff Danderyd Hospital · collabKarolinska University Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this double-blinded, placebo-controlled study is to test if treatment with Botulinum toxin-A is effective in reducing chronic muscle-related pain in adults with spastic cerebral palsy.

Timeline

Start
2015-08
Primary completion
2018-01-26
Completion
2018-10-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic — Intramuscular

Indications

spastic cerebral palsy